Ayro (AYRO) 10-Q 15 Mar 17 2017 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Jan. 31, 2017	Mar. 14, 2017
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jan. 31, 2017
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q3
Entity Registrant Name	WPCS INTERNATIONAL INC
Entity Central Index Key	1,086,745
Current Fiscal Year End Date	--04-30
Entity Filer Category	Smaller Reporting Company
Trading Symbol	WPCS
Entity Common Stock, Shares Outstanding		3,352,159

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Jan. 31, 2017	Apr. 30, 2016
Current assets:
Cash and cash equivalents	$ 2,340,707	$ 2,235,597
Accounts receivable, net of allowance of $206,000 and $92,000 at January 31, 2017 and April 30, 2016, respectively	3,662,932	2,886,154
Costs and estimated earnings in excess of billings on uncompleted contracts	330,724	357,210
Prepaid expenses and other current assets	124,330	66,256
Total current assets	6,458,693	5,545,217
Property and equipment, net	380,980	237,800
Other assets	14,305	21,162
Total assets	6,853,978	5,804,179
Current liabilities:
Current portion of loans payable	62,588	53,996
Accounts payable and accrued expenses	1,810,015	2,071,765
Billings in excess of costs and estimated earnings on uncompleted contracts	2,481,122	1,358,289
Total current liabilities	4,353,725	3,484,050
Loans payable, net of current portion	139,564	94,825
Total liabilities	4,493,289	3,578,875
Commitments and contingencies
Stockholders' equity
Common stock - $0.0001 par value, 100,000,000 shares authorized, 3,352,159 and 2,691,055 shares issued and outstanding as of January 31, 2017 and April 30, 2016, respectively	335	269
Additional paid-in capital	87,389,538	85,940,389
Accumulated deficit	(85,698,677)	(84,820,940)
Total stockholders' equity	2,360,689	2,225,304
Total liabilities and equity	6,853,978	5,804,179
Convertible Series H [Member]
Stockholders' equity
Preferred stock	1,242	406,262
Convertible Series H-1 [Member]
Stockholders' equity
Preferred stock	437,530	699,324
Convertible Series H-2 [Member]
Stockholders' equity
Preferred stock	$ 230,721	$ 0

CONDENSED CONSOLIDATED BALANCE3

CONDENSED CONSOLIDATED BALANCE SHEETS [Parenthetical] - USD ($)	Jan. 31, 2017	Apr. 30, 2016
Allowance for accounts receivable	$ 206,000	$ 92,000
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	5,000,000	5,000,000
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	3,352,159	2,691,055
Common stock, shares outstanding	3,352,159	2,691,055
Convertible Series H [Member]
Preferred stock, shares authorized	8,500	8,500
Preferred stock, shares issued	2,638	2,638
Preferred Stock, Shares Outstanding	2,638	2,638
Preferred Stock, liquidation preference (in dollars)	$ 1,000	$ 1,000
Convertible Series H-1 [Member]
Preferred stock, shares authorized	9,488	9,488
Preferred stock, shares issued	4,289	8,119
Preferred Stock, Shares Outstanding	4,289	8,119
Preferred Stock, liquidation preference (in dollars)	$ 712,000	$ 712,000
Convertible Series H-2 [Member]
Preferred stock, shares authorized	3,500	3,500
Preferred stock, shares issued	3,305	0
Preferred Stock, Shares Outstanding	3,305	0
Preferred Stock, liquidation preference (in dollars)	$ 400,000	$ 400,000

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Jan. 31, 2017	Jan. 31, 2016	Jan. 31, 2017	Jan. 31, 2016
Revenue	$ 4,263,709	$ 3,317,636	$ 12,527,872	$ 11,605,880
Costs and expenses:
Cost of revenue	3,235,871	2,521,627	9,690,566	9,263,395
Selling, general and administrative expenses	1,465,550	1,602,751	4,385,862	5,470,760
Depreciation and amortization	35,219	16,075	83,914	45,537
Costs and expenses	4,736,640	4,140,453	14,160,342	14,779,692
Operating loss	(472,931)	(822,817)	(1,632,470)	(3,173,812)
Other income (expense):
Interest expense	(2,430)	(523)	(5,440)	(2,021)
Income from Section 16 settlement	0	0	0	400,000
Income from arbitration settlement	0	0	1,180,902	0
Other income	20,394	4,871	142,828	1,965
Loss from continuing operations before income tax provision	(454,967)	(818,469)	(314,180)	(2,773,868)
Income tax provision	0	607	2,567	1,706
Loss from continuing operations	(454,967)	(819,076)	(316,747)	(2,775,574)
Discontinued operations:
Income from discontinued operations	0	0	0	41,261
Gain from disposal	0	0	0	837,720
Consolidated net income (loss)	(454,967)	(819,076)	(316,747)	(1,896,593)
Net income attributable to noncontrolling interest	0	0	0	16,505
Net loss attributable to WPCS	(454,967)	(819,076)	(316,747)	(1,913,098)
Dividends declared on preferred stock	0	(372,810)	0	(4,742,768)
Deemed dividend on convertible preferred stock, due to beneficial conversion feature	(541,266)	(40,729)	(560,990)	(744,499)
Net loss attributable to WPCS common shareholders	$ (996,233)	$ (1,232,615)	$ (877,737)	$ (7,400,365)
Basic and diluted loss from continuing operations per common share	$ (0.33)	$ (0.47)	$ (0.31)	$ (3.82)
Basic and diluted income from discontinued operations per common share	0	0	0	0.01
Basic and diluted net loss per common share	$ (0.33)	$ (0.47)	$ (0.31)	$ (3.81)
Basic and diluted weighted average number of common shares outstanding	2,976,670	2,597,952	2,844,101	2,161,104

CONDENSED CONSOLIDATED STATEME5

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME - USD ($)	3 Months Ended		9 Months Ended
	Jan. 31, 2017	Jan. 31, 2016	Jan. 31, 2017	Jan. 31, 2016
Consolidated net loss	$ (454,967)	$ (819,076)	$ (316,747)	$ (1,896,593)
Reclassification adjustments of other comprehensive loss on the sale of China operations	0	0	0	(349,723)
Comprehensive loss attributable to WPCS shareholders	$ (454,967)	$ (819,076)	$ (316,747)	$ (2,246,316)

CONDENSED CONSOLIDATED STATEME6

CONDENSED CONSOLIDATED STATEMENTS OF EQUITY - 9 months ended Jan. 31, 2017 - USD ($)	Total	Series H Preferred Stock [Member]	Series H-1 Preferred Convertible Stock [Member]	Series H-1 Preferred Stock [Member]	Series H-2 Preferred Stock [Member]	Series H-2 Convertible Preferred Stock [Member]	Preferred Stock [Member]	Preferred Stock [Member]Series H Preferred Stock [Member]	Preferred Stock [Member]Series H-1 Preferred Convertible Stock [Member]	Preferred Stock [Member]Series H-1 Preferred Stock [Member]	Preferred Stock [Member]Series H-2 Preferred Stock [Member]	Preferred Stock [Member]Series H-2 Convertible Preferred Stock [Member]	Common Stock [Member]	Common Stock [Member]Series H Preferred Stock [Member]	Common Stock [Member]Series H-1 Preferred Convertible Stock [Member]	Common Stock [Member]Series H-1 Preferred Stock [Member]	Common Stock [Member]Series H-2 Preferred Stock [Member]	Common Stock [Member]Series H-2 Convertible Preferred Stock [Member]	Additional Paid-in Capital [Member]	Additional Paid-in Capital [Member]Series H Preferred Stock [Member]	Additional Paid-in Capital [Member]Series H-1 Preferred Convertible Stock [Member]	Additional Paid-in Capital [Member]Series H-1 Preferred Stock [Member]	Additional Paid-in Capital [Member]Series H-2 Preferred Stock [Member]	Additional Paid-in Capital [Member]Series H-2 Convertible Preferred Stock [Member]	Accumulated Deficit [Member]	Accumulated Deficit [Member]Series H Preferred Stock [Member]	Accumulated Deficit [Member]Series H-1 Preferred Convertible Stock [Member]	Accumulated Deficit [Member]Series H-1 Preferred Stock [Member]	Accumulated Deficit [Member]Series H-2 Preferred Stock [Member]	Accumulated Deficit [Member]Series H-2 Convertible Preferred Stock [Member]
Balance at Apr. 30, 2016	$ 2,225,304						$ 1,105,586						$ 269						$ 85,940,389						$ (84,820,940)
Balance (in shares) at Jan. 31, 2017							7,602						3,352,159
Balance (in shares) at Apr. 30, 2016							10,757						2,691,055
Share based compensation	22,501						$ 0						$ 2						22,499						0
Share based compensation (in shares)							0						15,104
Issuance of Series H-2 preferred stock and warrants for cash					$ 429,631						$ 461,969						$ 0						$ (32,338)						$ 0
Issuance of Series H-2 preferred stock and warrants for cash (in shares)											3,305						0
Issuance of warrants with Series H-2 preferred stock					$ 0						$ (231,248)						$ 0						$ 231,248						$ 0
Beneficial conversion feature of Series H-2 convertible preferred stock						$ 0						$ (183,284)						$ 0						$ 183,284						$ 0
Deemed dividends related to immediate accretion of beneficial conversion feature of Series H-2 convertible preferred stock						$ 0						$ 183,284						$ 0						$ 0						$ (183,284)
Balance at Jan. 31, 2017	2,360,689						$ 669,493						$ 335						87,389,538						(85,698,677)
Conversion of Series preferred stock to common stock		$ 0		$ 0				$ (405,020)		$ (639,500)				$ 26		$ 38				$ 404,994		$ 639,462				$ 0		$ 0
Conversion of Series preferred stock to common stock (in shares)								(2,630)		(3,830)				263,000		383,000
Deemed dividend on conversion of Series H-1 convertible preferred stock to common stock			$ 0						$ 377,706						$ 0						$ 0						$ (377,706)
Net income	$ (316,747)						$ 0						$ 0						$ 0						$ (316,747)

CONDENSED CONSOLIDATED STATEME7

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Jan. 31, 2017	Jan. 31, 2016
Operating activities:
Net loss from operations	$ (316,747)	$ (2,775,574)
Consolidated net income from discontinued operations	0	878,981
Adjustments to reconcile consolidated net loss to net cash used in operating activities:
Depreciation and amortization	83,914	45,537
Shares based compensation	22,501	2,219,068
Gain on sale of China operations	0	(837,720)
Income on Section 16 settlement	0	(400,000)
Changes in operating assets and liabilities:
Accounts receivable	(776,778)	2,725,507
Costs and estimated earnings in excess of billings on uncompleted contracts	26,486	4,387
Current assets held for sale	0	(3,853,621)
Prepaid expenses and other current assets	(58,074)	66,211
Other assets	6,857	(2,110)
Other assets held for sale	0	(34,523)
Accounts payable and accrued expenses	(261,750)	(3,149,544)
Current liabilities held for sale	0	2,200,030
Billings in excess of costs and estimated earnings on uncompleted contracts	1,122,833	374,840
Net cash used in operating activities	(150,758)	(2,538,531)
Investing activities:
Acquisition of property and equipment	(104,069)	(109,851)
Proceeds from sale of China operations, net of acquisition cost	0	1,325,744
Net cash (used in) provided by investing activities	(104,069)	1,215,893
Financing activities:
Borrowings under loan payable obligations	0	99,369
Repayment under loan payable obligations	(69,694)	(35,304)
Repayments under other payable to Zurich	0	(360,000)
Repayments of short term convertible note	0	(4,000)
Net cash provided by financing activities	359,937	1,275,065
Effect of exchange rate changes on cash	0	91,510
Net increase in cash and cash equivalents	105,110	43,937
Cash and cash equivalents, beginning of the period	2,235,597	2,364,360
Cash and cash equivalents, end of the period	2,340,707	2,408,297
Schedule of non-cash investing and financing activities:
Automobile financing	123,025	0
Declaration on preferred dividend payable	0	4,742,768
Deemed dividend on conversion of convertible preferred stock to common stock	560,990	744,499
Conversion of dividends payable related to make-whole amount to common stock	0	4,457,356
Issuance Of Warrants With Series H-2 Preferred Stock	231,248	0
Beneficial conversion feature of Series H-2 convertible preferred stock	183,284	0
Series H-2 Preferred Stock [Member]
Financing activities:
Proceeds from issuance of preferred stock and warrants	429,631	0
Series H-2 Convertible Preferred Stock [Member]
Schedule of non-cash investing and financing activities:
Deemed dividend on conversion of convertible preferred stock to common stock	183,284	0
Series F-1 Preferred Stock [Member]
Schedule of non-cash investing and financing activities:
Conversion of dividends payable related to make-whole amount to common stock	0	624,977
Series G-1 Preferred Stock [Member]
Schedule of non-cash investing and financing activities:
Conversion of dividends payable related to make-whole amount to common stock	0	337,981
Series H Preferred Stock [Member]
Schedule of non-cash investing and financing activities:
Conversion of preferred stock through the issuance of common stock	405,020	892,680
Conversion of preferred stock through the issuance of common stock	0	1,299,000
Series F And F1 Preferred Stock [Member]
Schedule of non-cash investing and financing activities:
Conversion of preferred stock through the issuance of common stock	0	3,292,741
Series G And G1 Preferred Stock [Member]
Schedule of non-cash investing and financing activities:
Conversion of preferred stock through the issuance of common stock	0	1,827,927
Series H-1 Preferred Stock [Member]
Financing activities:
Proceeds from issuance of preferred stock and warrants	0	1,575,000
Schedule of non-cash investing and financing activities:
Conversion of preferred stock through the issuance of common stock	639,500	75,000
Beneficial conversion feature of Series H-2 convertible preferred stock	$ 377,706	$ 0

DESCRIPTION OF THE BUSINESS AND

DESCRIPTION OF THE BUSINESS AND BASIS OF PRESENTATION	9 Months Ended
	Jan. 31, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
DESCRIPTION OF THE BUSINESS AND BASIS OF PRESENTATION	NOTE 1 – DESCRIPTION OF THE BUSINESS AND BASIS OF PRESENTATION Description of the Business WPCS International Incorporated, a Delaware corporation (“WPCS”) and its wholly and majority-owned subsidiaries (collectively, the “Company”) currently specializes in low voltage communications, audio-visual and security contracting services, conducting business in one segment at one operations center, through its wholly-owned domestic subsidiary, WPCS International - Suisun City, Inc. (“Suisun City Operations”). During the quarter ended January 31, 2017 the Company began winding down its operations from its wholly-owned Texas subsidiary, WPCS International-Texas, Inc. (“Texas Operations”). The Company is a full-service low voltage contractor that specializes in the installation and service of Voice & Data Networks, Security Systems, Audio-Visual Solutions, and Distributed Antenna Systems and provides experienced project management and delivers complex projects to key vertical markets that include Healthcare, Education, Transportation, Energy & Utilities, Oil & Gas, Manufacturing, Commercial Real Estate, Financial, Government, etc. Basis of Presentation The condensed consolidated financial statements of WPCS and its wholly and majority-owned subsidiaries included in this Report for the three and nine months ended January 31, 2017 and 2016, reflect the accounts of current and former entities as either continued or discontinued operations, as discussed below. Continuing operations for the three and nine months ended January 31, 2017 and 2016 include the results of operations of: (i) WPCS (which primarily reflects corporate operating expenses and nonoperating income); (ii) Suisun City Operations and the Texas Operations, (the Texas Operations were closed in February 2017and therefore the Suisun Operation remains the Company’s only active operating subsidiary); (iii) WPCS Incorporated, an inactive subsidiary; and (iv) WPCS International – Trenton, Inc. (“Trenton Operations”), which operations were closed in September 2013. Discontinued operations for the three and nine months ended January 31, 2016 include the results of WPCS Asia Limited, a 60 The unaudited condensed consolidated financial information furnished herein reflects all adjustments (consisting of normal recurring accruals) which are, in the opinion of management, considered necessary for a fair presentation of the financial position and the results of operations and cash flows of the Company for the periods presented. All intercompany accounts and transactions have been eliminated in consolidation. These unaudited condensed consolidated financial statements of the Company have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") for interim financial information. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. These interim condensed consolidated financial statements should be read in conjunction with the financial statements included in the Annual Report on Form 10-K for the fiscal year ended April 30, 2016. The results of operations for the three and nine months ended January 31, 2017 are not necessarily indicative of the results to be expected for the full fiscal year.

LIQUIDITY AND CAPITAL RESOURCES

LIQUIDITY AND CAPITAL RESOURCES	9 Months Ended
	Jan. 31, 2017
Liquidity and Capital Resources [Abstract]
LIQUIDITY AND CAPITAL RESOURCES	NOTE 2 – LIQUIDITY AND CAPITAL RESOURCES As of January 31, 2017, the Company had a working capital surplus of approximately $ 2,105,000 2,341,000 The Company's future plans and growth are dependent on its ability to increase revenues and continue its business development efforts surrounding its contract award backlog. If the Company continues to incur losses and revenues do not generate from the backlog as expected, the Company may need to raise additional capital to expand its business and continue as a going concern. The Company currently anticipates that its current cash position will be sufficient to meet its working capital requirements to continue its sales and marketing efforts for at least 12 months from the filing date of this report. If in the future the Company’s plans or assumptions change or prove to be inaccurate, the Company may need to raise additional funds through public or private debt or equity offerings, financings, corporate collaborations, or other means. The Company may also be required to reduce operating expenditures or investments in its infrastructure.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Jan. 31, 2017
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies There have been no material changes in the Company’s significant accounting policies to those previously disclosed in the Form 10-K for the year ended April 30, 2016. In August 2014, the FASB issued Accounting Standards Update (“ASU”) 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern In November 2015, the FASB issued ASU 2015-17, Balance Sheet Classification of Deferred Taxes The Company adopted this guidance as of January 31, 2017 on a prospective basis, and its adoption did not have any significant impact on the Company’s consolidated financial statements. In August 2016, the FASB issued ASU No. 2016-15 Statement of Cash Flows - Classification of Certain Cash Receipts and Cash Payments, which addresses specific cash flow classification issues where there is currently diversity in practice including debt prepayment and proceeds from the settlement of insurance claims. ASU 2016-15 is effective for annual periods beginning after December 15, 2017, with early adoption permitted. The Company elected to early adopt ASU 2016-15 effective as of January 31, 2017. The adoption of ASU 2016-15 did not impact our results of operations or cash flows. In November 2016, the FASB issued ASU No. 2016-18 Statement of Cash Flows - Restricted Cash, which requires entities to show the changes in the total of cash, cash equivalents, restricted cash and restricted cash equivalents in the statement of cash flows. As a result, entities will no longer present transfers between cash and cash equivalents and restricted cash and restricted cash equivalents in the statement of cash flows. ASU 2016-18 is effective for annual periods beginning after December 15, 2017, with early adoption permitted. The Company elected to early adopt ASU 2016-18 including retrospective adoption for all prior periods. The impact of the adoption of ASU 2016-18 is the addition of a reconciliation of the totals in the statement of cash flows to the related captions in the balance sheet. Recent Accounting Pronouncements In May 2014, the FASB issued ASU No. 2014-09, “Revenue from Contracts with Customers (Topic 606)” (“ASU 2014-09”). ASU 2014-09 amends the guidance for revenue recognition to replace numerous, industry-specific requirements and converges areas under this topic with those of the International Financial Reporting Standards. The ASU implements a five-step process for customer contract revenue recognition that focuses on transfer of control, as opposed to transfer of risk and rewards. The amendment also requires enhanced disclosures regarding the nature, amount, timing and uncertainty of revenues and cash flows from contracts with customers. Other major provisions include the capitalization and amortization of certain contract costs, ensuring the time value of money is considered in the transaction price, and allowing estimates of variable consideration to be recognized before contingencies are resolved in certain circumstances. The amendments of ASU 2014-09 were effective for reporting periods beginning after December 15, 2016, with early adoption prohibited. Entities can transition to the standard either retrospectively or as a cumulative-effect adjustment as of the date of adoption. Subsequent to issuing ASU 2014-09, the FASB issued the following amendments concerning the adoption and clarification of ASU 2014-09. In August 2015, the FASB issued ASU No. 2015-14 “Revenue from Contracts with Customers (Topic 606), Deferral of the Effective Date” (“ASU 2015-14”), which deferred the effective date one year. As a result, the amendments of ASU 2014-09 are effective for reporting periods beginning after December 15, 2017, with early adoption permitted only as of annual reporting periods beginning after December 15, 2016. In March 2016, the FASB issued ASU No. 2016-08 “Revenue from Contracts with Customers (Topic 606), Principal versus Agent Considerations (Reporting Revenue versus Net)” (“ASU 2016-08”), which clarifies the implementation guidance on principal versus agent considerations in the new revenue recognition standard. ASU 2016-08 clarifies how an entity should identify the unit of accounting (i.e. the specified good or service) for the principal versus agent evaluation and how it should apply the control principle to certain types of arrangements. In April 2016, the FASB issued ASU No. 2016-10 “Revenue from Contracts with Customers (Topic 606), Identifying Performance Obligations and Licensing” (“ASU 2016-10”), which reduces the complexity when applying the guidance for identifying performance obligations and improves the operability and understandability of the license implementation guidance. In May 2016, the FASB issued ASU No. 2016-12 “Revenue from Contracts with Customers (Topic 606), Narrow-Scope Improvements and Practical Expedients” (“ASU 2016-12”), which amends the guidance on transition, collectability, noncash consideration and the presentation of sales and other similar taxes. ASU 2016-12 clarifies that, for a contract to be considered completed at transition, all (or substantially all) of the revenue must have been recognized under legacy GAAP. In addition, ASU 2016-12 clarifies how an entity should evaluate the collectability threshold and when an entity can recognize nonrefundable consideration received as revenue if an arrangement does not meet the standard’s contract criteria. The Company is currently evaluating the potential impact the adoption of these ASUs may have on its financial statements and related disclosures. In March 2016, the FASB issued ASU 2016-09, Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting. The amendment is to simplify several aspects of the accounting for share-based payment transactions including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. For public entities, the amendments in ASU 2016-09 are effective for interim and annual reporting periods beginning after December 15, 2016. The Company will adopt this guidance as of and for the year ended April 30, 2017. The Company does not expect the adoption of ASU 2016-09 to have a material impact on its consolidated financial statements and related disclosures. In January 2017, the FASB issued an ASU 2017-01, Business Combinations (Topic 805) Clarifying the Definition of a Business. The amendments in this Update is to clarify the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. The definition of a business affects many areas of accounting including acquisitions, disposals, goodwill, and consolidation. The guidance is effective for annual periods beginning after December 15, 2017, including interim periods within those periods. The Company is currently evaluating the impact of adopting this guidance. Accounting standards that have been issued or proposed by the Financial Accounting Standards Board (“FASB”), Securities and Exchange Commission (“SEC”) or other standard setting bodies that do not require adoption until a future date are not expected to have a material impact on the consolidated financial statements upon adoption. Reclassifications Certain reclassifications have been made in prior years’ condensed consolidated financial statements to conform to the current year’s presentation. These reclassifications reflect the results of the China Operations as discontinued operations for all periods presented.

CONCENTRATIONS

CONCENTRATIONS	9 Months Ended
	Jan. 31, 2017
Risks and Uncertainties [Abstract]
CONCENTRATIONS	NOTE 4 – CONCENTRATIONS Accounts Receivable As of January 31, 2017 April 30, 2016 Customer A 16 % - Customer B 10 % 21 % Customer C - 10 % Customer D - 34 % The accounts receivable also included retainage receivable of $ 646,000 326,000 Revenue Recognition For the three months ended For the nine months ended January 31, January 31, 2017 2016 2017 2016 Customer A 20 % - 13 % 9 % Customer B - - - 11 % Customer C - 11 % - - Customer D 13 % - - - - Represents less than 10%

BASIC AND DILUTED NET (LOSS) IN

BASIC AND DILUTED NET (LOSS) INCOME PER COMMON SHARE	9 Months Ended
	Jan. 31, 2017
Earnings Per Share [Abstract]
BASIC AND DILUTED NET LOSS PER COMMON SHARE	NOTE 5 – BASIC AND DILUTED NET (LOSS) INCOME PER COMMON SHARE Basic and diluted net income (loss) per common share from continuing operations is computed as net income (loss) from continuing operations less non-controlling interest and dividends on preferred stock, divided by the weighted average number of common shares outstanding for the period. Diluted net income per common share reflects the potential dilution that could occur from common stock issuable through the exercise of stock options and warrants and note conversions. As of January 31, 2017 2016 Common stock equivalents: Common stock options 2,422,000 2824000 Series H, H-1 and H-2 preferred stock 760,000 1,076,000 Common stock purchase warrants 1,791,000 1,295,000 Totals 4,973,000 5,195,000

COSTS AND ESTIMATED EARNINGS ON

COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS	9 Months Ended
	Jan. 31, 2017
Contractors [Abstract]
COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS	NOTE 6 – COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS Costs and estimated earnings in excess of billings on uncompleted contracts represents revenue recognized in excess of amounts billed. The liability, “Billings in excess of costs and estimated earnings on uncompleted contracts”, represents billings in excess of revenue recognized. January 31, 2017 April 30, 2016 Costs incurred on uncompleted contracts $ 17,338,966 $ 28,884,776 Estimated contract earnings 3,937,103 4,367,463 21,276,069 33,252,239 Less: Billings to date 23,426,467 34,253,318 Total $ (2,150,398) $ (1,001,079) Costs and estimated earnings in excess of billings on uncompleted contracts $ 330,724 $ 357,210 Billings in excess of cost and estimated earnings on uncompleted contracts 2,481,122 1,358,289 Total $ (2,150,398) $ (1,001,079) Revisions in the estimated gross profits on contracts and contract amounts are made in the period in which circumstances requiring the revisions become known. Although management believes it has established adequate procedures for estimating costs to complete on open contracts, it is at least reasonably possible that additional significant costs could occur on contracts prior to completion.

DISCONTINUED OPERATIONS

DISCONTINUED OPERATIONS	9 Months Ended
	Jan. 31, 2017
Discontinued Operations
DISCONTINUED OPERATIONS	NOTE 7 – DISCONTINUED OPERATIONS The Company previously disclosed the details regarding the sales of its China Operations in its Form 10-K filed for the year ended April 30, 2016. For the three months ended For the nine months ended January 31, January 31, 2016 2016 Revenue $ - $ 839,969 Costs and expenses: Cost of revenue - 546,296 Selling, general and administrative expenses - 111,324 Depreciation and amortization - 80,971 - 738,591 Operating income from discontinued operations - 101,378 Interest expense - (49,234) Income from discontinued operations before income tax provision - 52,144 Income tax provision - (10,883) Income from discontinued operations, net of tax - 41,261 Gain from disposal - 837,720 Total income from discontinued operations $ - $ 878,981 Due to Related Party The China Operations earned revenue for contracting services provided to TGG (noncontrolling interest in China Operations) and subsidiaries of $ 0 0 212,000

INCOME FROM SECTION 16 SETTLEME

INCOME FROM SECTION 16 SETTLEMENT	9 Months Ended
	Jan. 31, 2017
Income From Section Sixteen Settlements [Abstract]
INCOME FROM SECTION 16 SETTEMENTS	NOTE 8 – INCOME FROM SECTION 16 SETTLEMENT For the three and nine months ended January 31, 2016, the Company received $ 0 400,000

BANK LINE OF CREDIT

BANK LINE OF CREDIT	9 Months Ended
	Jan. 31, 2017
Line of Credit Facility [Abstract]
BANK LINE OF CREDIT	NOTE 9 – BANK LINE OF CREDIT On May 20, 2015 1,000,000 August 15, 2017 2 1.0 As of the filing date of this report, the Company has not drawn down on the line of credit.

LOANS PAYABLE

LOANS PAYABLE	9 Months Ended
	Jan. 31, 2017
Debt Disclosure [Abstract]
LOANS PAYABLE	NOTE 10 – LOANS PAYABLE Carrying Value Stated as of Estimated Future Payment Maturity Date Interest Rate January 31, 2017 Within 1 Year After 1 year 0% automobile loan payable April 2018 - June 2019 0.0% $ 26,000 $ 13,000 $ 14,000 1% automobile loan payable November 2022 1.0% 24,000 4,000 20,000 3% automobile loan payable November 2022 3.0% 25,000 5,000 20,000 4% automobile loan payable December 2016 - January 2020 4.0% 32,000 15,000 17,000 5% automobile loan payable January 2020 - February 2020 5.0% 54,000 17,000 37,000 7% automobile loan payable June 2019 7.0% 25,000 5,000 20,000 8% automobile loan payable October 2021 8.0% 16,000 3,000 13,000 $ 202,000 $ 62,000 $ 141,000 Carrying Value Stated as of Estimated Future Payment Maturity Date Interest Rate April 30, 2016 Within 1 Year After 1 year 0% automobile loan payable April 2018 - May 2019 0.0% $ 25,000 $ 10,000 $ 15,000 4% automobile loan payable August 2016 - January 2020 4.0% 58,000 28,000 30,000 5% automobile loan payable January 2020 - February 2020 5.0% 66,000 16,000 50,000 $ 149,000 $ 54,000 $ 95,000

STOCKHOLDERS' EQUITY

STOCKHOLDERS' EQUITY	9 Months Ended
	Jan. 31, 2017
Stockholders' Equity Note [Abstract]
STOCKHOLDERS’ EQUITY	NOTE 11 – STOCKHOLDERS’ EQUITY Conversion of Preferred Shares – Series H and H-1 For the nine months ended January 31, 2017, holders of the Company’s Series H Convertible Preferred Stock (“Series H Shares”) have converted 2,630 263,000 For the nine months ended January 31, 2017, holders of the Company’s Series H-1 Convertible Preferred Stock (“Series H-1 Shares”) have converted 3,830 383,000 378,000 Issuance of Preferred Shares – Series H-2 On December 21, 2016, the Company entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with two investors pursuant to which the Company issued to the investors an aggregate of 3,305 0.0001 495,750 1.21 462,000 The Company has determined that the Warrants qualify for accounting as equity classification. On the issuance date, the Company estimated the fair value of the Warrants at $ 462,000 5.0 238 2 0 231,000 Due to the reduction of allocated proceeds to Series H-2 Shares, the effective conversion price was approximately $ 0.60 183,000 Registration Statement The Company filed a registration statement on January 25, 2017, for the common shares underlying the series H-2 Preferred Stock and Warrants, and it was declared effective on January 31, 2017 .

INCOME FROM ARBITRATION SETTLEM

INCOME FROM ARBITRATION SETTLEMENTS	9 Months Ended
	Jan. 31, 2017
Income From Legal Settlements [Abstract]
INCOME FROM ARBITRATION SETTLEMENTS	NOTE 12 – INCOME FROM ARBITRATION SETTLEMENTS On June 16, 2016, the Company entered into a global settlement agreement and mutual release to resolve all disputes and claims regarding the construction of the Cooper Medical School at Rowan University, located in Camden, New Jersey, in which the Company served as an electrical prime contractor. As a result of such settlement, the Company received proceeds of $ 1,150,000

SUMMARY OF SIGNIFICANT ACCOUN20

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Jan. 31, 2017
Accounting Policies [Abstract]
Significant Accounting Policies	Significant Accounting Policies There have been no material changes in the Company’s significant accounting policies to those previously disclosed in the Form 10-K for the year ended April 30, 2016.
Adoption of Recent Accounting Pronouncements	In August 2014, the FASB issued Accounting Standards Update (“ASU”) 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern In November 2015, the FASB issued ASU 2015-17, Balance Sheet Classification of Deferred Taxes The Company adopted this guidance as of January 31, 2017 on a prospective basis, and its adoption did not have any significant impact on the Company’s consolidated financial statements. In August 2016, the FASB issued ASU No. 2016-15 Statement of Cash Flows - Classification of Certain Cash Receipts and Cash Payments, which addresses specific cash flow classification issues where there is currently diversity in practice including debt prepayment and proceeds from the settlement of insurance claims. ASU 2016-15 is effective for annual periods beginning after December 15, 2017, with early adoption permitted. The Company elected to early adopt ASU 2016-15 effective as of January 31, 2017. The adoption of ASU 2016-15 did not impact our results of operations or cash flows. In November 2016, the FASB issued ASU No. 2016-18 Statement of Cash Flows - Restricted Cash, which requires entities to show the changes in the total of cash, cash equivalents, restricted cash and restricted cash equivalents in the statement of cash flows. As a result, entities will no longer present transfers between cash and cash equivalents and restricted cash and restricted cash equivalents in the statement of cash flows. ASU 2016-18 is effective for annual periods beginning after December 15, 2017, with early adoption permitted. The Company elected to early adopt ASU 2016-18 including retrospective adoption for all prior periods. The impact of the adoption of ASU 2016-18 is the addition of a reconciliation of the totals in the statement of cash flows to the related captions in the balance sheet.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In May 2014, the FASB issued ASU No. 2014-09, “Revenue from Contracts with Customers (Topic 606)” (“ASU 2014-09”). ASU 2014-09 amends the guidance for revenue recognition to replace numerous, industry-specific requirements and converges areas under this topic with those of the International Financial Reporting Standards. The ASU implements a five-step process for customer contract revenue recognition that focuses on transfer of control, as opposed to transfer of risk and rewards. The amendment also requires enhanced disclosures regarding the nature, amount, timing and uncertainty of revenues and cash flows from contracts with customers. Other major provisions include the capitalization and amortization of certain contract costs, ensuring the time value of money is considered in the transaction price, and allowing estimates of variable consideration to be recognized before contingencies are resolved in certain circumstances. The amendments of ASU 2014-09 were effective for reporting periods beginning after December 15, 2016, with early adoption prohibited. Entities can transition to the standard either retrospectively or as a cumulative-effect adjustment as of the date of adoption. Subsequent to issuing ASU 2014-09, the FASB issued the following amendments concerning the adoption and clarification of ASU 2014-09. In August 2015, the FASB issued ASU No. 2015-14 “Revenue from Contracts with Customers (Topic 606), Deferral of the Effective Date” (“ASU 2015-14”), which deferred the effective date one year. As a result, the amendments of ASU 2014-09 are effective for reporting periods beginning after December 15, 2017, with early adoption permitted only as of annual reporting periods beginning after December 15, 2016. In March 2016, the FASB issued ASU No. 2016-08 “Revenue from Contracts with Customers (Topic 606), Principal versus Agent Considerations (Reporting Revenue versus Net)” (“ASU 2016-08”), which clarifies the implementation guidance on principal versus agent considerations in the new revenue recognition standard. ASU 2016-08 clarifies how an entity should identify the unit of accounting (i.e. the specified good or service) for the principal versus agent evaluation and how it should apply the control principle to certain types of arrangements. In April 2016, the FASB issued ASU No. 2016-10 “Revenue from Contracts with Customers (Topic 606), Identifying Performance Obligations and Licensing” (“ASU 2016-10”), which reduces the complexity when applying the guidance for identifying performance obligations and improves the operability and understandability of the license implementation guidance. In May 2016, the FASB issued ASU No. 2016-12 “Revenue from Contracts with Customers (Topic 606), Narrow-Scope Improvements and Practical Expedients” (“ASU 2016-12”), which amends the guidance on transition, collectability, noncash consideration and the presentation of sales and other similar taxes. ASU 2016-12 clarifies that, for a contract to be considered completed at transition, all (or substantially all) of the revenue must have been recognized under legacy GAAP. In addition, ASU 2016-12 clarifies how an entity should evaluate the collectability threshold and when an entity can recognize nonrefundable consideration received as revenue if an arrangement does not meet the standard’s contract criteria. The Company is currently evaluating the potential impact the adoption of these ASUs may have on its financial statements and related disclosures. In March 2016, the FASB issued ASU 2016-09, Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting. The amendment is to simplify several aspects of the accounting for share-based payment transactions including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. For public entities, the amendments in ASU 2016-09 are effective for interim and annual reporting periods beginning after December 15, 2016. The Company will adopt this guidance as of and for the year ended April 30, 2017. The Company does not expect the adoption of ASU 2016-09 to have a material impact on its consolidated financial statements and related disclosures. In January 2017, the FASB issued an ASU 2017-01, Business Combinations (Topic 805) Clarifying the Definition of a Business. The amendments in this Update is to clarify the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. The definition of a business affects many areas of accounting including acquisitions, disposals, goodwill, and consolidation. The guidance is effective for annual periods beginning after December 15, 2017, including interim periods within those periods. The Company is currently evaluating the impact of adopting this guidance. Accounting standards that have been issued or proposed by the Financial Accounting Standards Board (“FASB”), Securities and Exchange Commission (“SEC”) or other standard setting bodies that do not require adoption until a future date are not expected to have a material impact on the consolidated financial statements upon adoption.
Reclassifications	Reclassifications Certain reclassifications have been made in prior years’ condensed consolidated financial statements to conform to the current year’s presentation. These reclassifications reflect the results of the China Operations as discontinued operations for all periods presented.

CONCENTRATIONS (Tables)

CONCENTRATIONS (Tables)	9 Months Ended
	Jan. 31, 2017
Sales Revenue, Net [Member]
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]	The concentration of revenue recognition for the three and nine months ended January 31, 2017 and 2016, respectively are as follows: For the three months ended For the nine months ended January 31, January 31, 2017 2016 2017 2016 Customer A 20 % - 13 % 9 % Customer B - - - 11 % Customer C - 11 % - - Customer D 13 % - - -
Accounts Receivable [Member]
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]	The concentration of accounts receivable as of January 31, 2017 and April 30, 2016, respectively are as follows: As of January 31, 2017 April 30, 2016 Customer A 16 % - Customer B 10 % 21 % Customer C - 10 % Customer D - 34 %

BASIC AND DILUTED NET (LOSS) 22

BASIC AND DILUTED NET (LOSS) INCOME PER COMMON SHARE (Tables)	9 Months Ended
	Jan. 31, 2017
Earnings Per Share [Abstract]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The following securities were excluded from the weighted average dilutive common shares outstanding because their inclusion would have been antidilutive. As of January 31, 2017 2016 Common stock equivalents: Common stock options 2,422,000 2824000 Series H, H-1 and H-2 preferred stock 760,000 1,076,000 Common stock purchase warrants 1,791,000 1,295,000 Totals 4,973,000 5,195,000

COSTS AND ESTIMATED EARNINGS 23

COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS (Tables)	9 Months Ended
	Jan. 31, 2017
Contractors [Abstract]
Schedule of Costs and Estimated Earnings on Uncompleted Contracts	Costs and estimated earnings on uncompleted contracts consist of the following at January 31, 2017 and April 30, 2016: January 31, 2017 April 30, 2016 Costs incurred on uncompleted contracts $ 17,338,966 $ 28,884,776 Estimated contract earnings 3,937,103 4,367,463 21,276,069 33,252,239 Less: Billings to date 23,426,467 34,253,318 Total $ (2,150,398) $ (1,001,079) Costs and estimated earnings in excess of billings on uncompleted contracts $ 330,724 $ 357,210 Billings in excess of cost and estimated earnings on uncompleted contracts 2,481,122 1,358,289 Total $ (2,150,398) $ (1,001,079)

DISCONTINUED OPERATIONS (Tables

DISCONTINUED OPERATIONS (Tables)	9 Months Ended
	Jan. 31, 2017
Discontinued Operations
Schedule of Disposal Groups, Including Discontinued Operations, Income Statement	The schedule below shows the results of discontinued operations from China for the three and nine months ended January 31, 2016. For the three months ended For the nine months ended January 31, January 31, 2016 2016 Revenue $ - $ 839,969 Costs and expenses: Cost of revenue - 546,296 Selling, general and administrative expenses - 111,324 Depreciation and amortization - 80,971 - 738,591 Operating income from discontinued operations - 101,378 Interest expense - (49,234) Income from discontinued operations before income tax provision - 52,144 Income tax provision - (10,883) Income from discontinued operations, net of tax - 41,261 Gain from disposal - 837,720 Total income from discontinued operations $ - $ 878,981

LOANS PAYABLE (Tables)

LOANS PAYABLE (Tables)	9 Months Ended
	Jan. 31, 2017
Debt Disclosure [Abstract]
Schedule of Debt [Table Text Block]	The following tables summarize outstanding loans payable related to automobiles as of January 31, 2017 and April 30, 2016, respectively: Carrying Value Stated as of Estimated Future Payment Maturity Date Interest Rate January 31, 2017 Within 1 Year After 1 year 0% automobile loan payable April 2018 - June 2019 0.0% $ 26,000 $ 13,000 $ 14,000 1% automobile loan payable November 2022 1.0% 24,000 4,000 20,000 3% automobile loan payable November 2022 3.0% 25,000 5,000 20,000 4% automobile loan payable December 2016 - January 2020 4.0% 32,000 15,000 17,000 5% automobile loan payable January 2020 - February 2020 5.0% 54,000 17,000 37,000 7% automobile loan payable June 2019 7.0% 25,000 5,000 20,000 8% automobile loan payable October 2021 8.0% 16,000 3,000 13,000 $ 202,000 $ 62,000 $ 141,000 Carrying Value Stated as of Estimated Future Payment Maturity Date Interest Rate April 30, 2016 Within 1 Year After 1 year 0% automobile loan payable April 2018 - May 2019 0.0% $ 25,000 $ 10,000 $ 15,000 4% automobile loan payable August 2016 - January 2020 4.0% 58,000 28,000 30,000 5% automobile loan payable January 2020 - February 2020 5.0% 66,000 16,000 50,000 $ 149,000 $ 54,000 $ 95,000

DESCRIPTION OF THE BUSINESS A26

DESCRIPTION OF THE BUSINESS AND BASIS OF PRESENTATION (Details Textual)	3 Months Ended		9 Months Ended
	Jan. 31, 2017	Jan. 31, 2016	Jan. 31, 2017	Jan. 31, 2016
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Percentage Of International Operation	0.00%	60.00%	0.00%	60.00%

LIQUIDITY AND CAPITAL RESOURC27

LIQUIDITY AND CAPITAL RESOURCES (Details Textual) - USD ($)	Jan. 31, 2017	Apr. 30, 2016	Jan. 31, 2016	Apr. 30, 2015
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Working Capital Surplus	$ 2,105,000
Cash and Cash Equivalents, at Carrying Value, Total	$ 2,340,707	$ 2,235,597	$ 2,408,297	$ 2,364,360

CONCENTRATIONS (Details)

CONCENTRATIONS (Details)	3 Months Ended		9 Months Ended		12 Months Ended
	Jan. 31, 2017	Jan. 31, 2016	Jan. 31, 2017	Jan. 31, 2016	Apr. 30, 2016
Accounts Receivable [Member]
Debt Instrument [Line Items]
Concentration Risk, Percentage			0.00%
Customer A Concetration Risk [Member] | Sales Revenue, Net [Member]
Debt Instrument [Line Items]
Concentration Risk, Percentage	20.00%	0.00%	13.00%	9.00%
Customer A Concetration Risk [Member] | Accounts Receivable [Member]
Debt Instrument [Line Items]
Concentration Risk, Percentage			16.00%		0.00%
Customer B Concetration Risk [Member] | Sales Revenue, Net [Member]
Debt Instrument [Line Items]
Concentration Risk, Percentage	0.00%	0.00%	0.00%	11.00%
Customer B Concetration Risk [Member] | Accounts Receivable [Member]
Debt Instrument [Line Items]
Concentration Risk, Percentage			10.00%		21.00%
Customer C Concetration Risk [Member] | Sales Revenue, Net [Member]
Debt Instrument [Line Items]
Concentration Risk, Percentage	0.00%	11.00%	0.00%	0.00%
Customer C Concetration Risk [Member] | Accounts Receivable [Member]
Debt Instrument [Line Items]
Concentration Risk, Percentage			0.00%		10.00%
Customer D Concetration Risk [Member] | Sales Revenue, Net [Member]
Debt Instrument [Line Items]
Concentration Risk, Percentage	13.00%	0.00%	0.00%	0.00%
Customer D Concetration Risk [Member] | Accounts Receivable [Member]
Debt Instrument [Line Items]
Concentration Risk, Percentage			0.00%		34.00%

CONCENTRATIONS (Details Textual

CONCENTRATIONS (Details Textual) - USD ($)	Jan. 31, 2017	Apr. 30, 2016
Concentration Risk [Line Items]
Contract Receivable Retainage, Total	$ 646,000	$ 326,000

BASIC AND DILUTED NET (LOSS) 30

BASIC AND DILUTED NET (LOSS) INCOME PER COMMON SHARE (Details) - shares	9 Months Ended
	Jan. 31, 2017	Jan. 31, 2016
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	4,973,000	5,195,000
Common stock options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	2,422,000	2,824,000
Series H, H-1 and H-2 Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	760,000	1,076,000
Common stock purchase warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	1,791,000	1,295,000

COSTS AND ESTIMATED EARNINGS 31

COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS (Details) - USD ($)	Jan. 31, 2017	Apr. 30, 2016
Costs incurred on uncompleted contracts	$ 17,338,966	$ 28,884,776
Estimated contract earnings	3,937,103	4,367,463
Gross Total	21,276,069	33,252,239
Less: Billings to date	23,426,467	34,253,318
Total	(2,150,398)	(1,001,079)
Costs and estimated earnings in excess of billings on uncompleted contracts	330,724	357,210
Billings in excess of cost and estimated earnings on uncompleted contracts	2,481,122	1,358,289
Total	$ (2,150,398)	$ (1,001,079)

DISCONTINUED OPERATIONS (Detail

DISCONTINUED OPERATIONS (Details) - USD ($)	3 Months Ended		9 Months Ended
	Jan. 31, 2017	Jan. 31, 2016	Jan. 31, 2017	Jan. 31, 2016
Revenue		$ 0		$ 839,969
Costs and expenses:
Cost of revenue		0		546,296
Selling, general and administrative expenses		0		111,324
Depreciation and amortization		0		80,971
Disposal Group, Including Discontinued Operation, Operating Expense		0		738,591
Operating income from discontinued operations		0		101,378
Interest expense		0		(49,234)
Income from discontinued operations before income tax provision		0		52,144
Income tax provision		0		(10,883)
Income from discontinued operations, net of tax	$ 0	0	$ 0	41,261
Gain from disposal	$ 0	0	$ 0	837,720
Total income from discontinued operations		$ 0		$ 878,981

DISCONTINUED OPERATIONS (Deta33

DISCONTINUED OPERATIONS (Details Textual) - USD ($)	3 Months Ended		9 Months Ended
	Jan. 31, 2017	Jan. 31, 2016	Jan. 31, 2017	Jan. 31, 2016
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Disposal Group, Including Discontinued Operation, Revenue		$ 0		$ 839,969
China Operations [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Disposal Group, Including Discontinued Operation, Revenue	$ 0	$ 0	$ 0	$ 212,000

INCOME FROM SECTION 16 SETTLE34

INCOME FROM SECTION 16 SETTLEMENT (Details Textual) - USD ($)	3 Months Ended		9 Months Ended
	Jan. 31, 2017	Jan. 31, 2016	Jan. 31, 2017	Jan. 31, 2016
Income From Section Sixteen Settlements [Line Items]
Proceeds from Legal Settlements	$ 0	$ 0	$ 0	$ 400,000

BANK LINE OF CREDIT (Details Te

BANK LINE OF CREDIT (Details Textual) - USD ($)	1 Months Ended
	May 20, 2015	Jan. 31, 2017
Line of Credit Facility [Line Items]
Line of Credit Facility, Expiration Date	Aug. 15, 2017
Revolving Credit Facility [Member]
Line of Credit Facility [Line Items]
Proceeds from Lines of Credit	$ 1,000,000
Line of Credit Facility, Initiation Date	May 20, 2015
Line of Credit Facility, Interest Rate During Period	2.00%
Line of Credit Facility, Maximum Borrowing Capacity		$ 1,000,000

LOANS PAYABLE (Details)

LOANS PAYABLE (Details) - USD ($)	9 Months Ended	12 Months Ended
	Jan. 31, 2017	Apr. 30, 2016
Debt Instrument [Line Items]
Carrying Value	$ 202,000	$ 149,000
Estimated Future Payment Within 1 Year	62,000	54,000
Estimated Future Payment After 1 year	$ 141,000	$ 95,000
0% automobile loan payable [Member]
Debt Instrument [Line Items]
Maturity Date	April 2018 - June 2019	April 2018 - May 2019
Stated Interest Rate	0.00%	0.00%
Carrying Value	$ 26,000	$ 25,000
Estimated Future Payment Within 1 Year	13,000	10,000
Estimated Future Payment After 1 year	$ 14,000	$ 15,000
1% automobile loan payable [Member]
Debt Instrument [Line Items]
Maturity Date	November 2,022
Stated Interest Rate	1.00%
Carrying Value	$ 24,000
Estimated Future Payment Within 1 Year	4,000
Estimated Future Payment After 1 year	$ 20,000
3% automobile loan payable [Member]
Debt Instrument [Line Items]
Maturity Date	November 2,022
Stated Interest Rate	3.00%
Carrying Value	$ 25,000
Estimated Future Payment Within 1 Year	5,000
Estimated Future Payment After 1 year	$ 20,000
4% automobile loan payable [Member]
Debt Instrument [Line Items]
Maturity Date	December 2016 - January 2020	August 2016 - January 2020
Stated Interest Rate	4.00%	4.00%
Carrying Value	$ 32,000	$ 58,000
Estimated Future Payment Within 1 Year	15,000	28,000
Estimated Future Payment After 1 year	$ 17,000	$ 30,000
5% automobile loan payable [Member]
Debt Instrument [Line Items]
Maturity Date	January 2020 - February 2020	January 2020 - February 2020
Stated Interest Rate	5.00%	5.00%
Carrying Value	$ 54,000	$ 66,000
Estimated Future Payment Within 1 Year	17,000	16,000
Estimated Future Payment After 1 year	$ 37,000	$ 50,000
7% automobile loan payable [Member]
Debt Instrument [Line Items]
Maturity Date	June 2,019
Stated Interest Rate	7.00%
Carrying Value	$ 25,000
Estimated Future Payment Within 1 Year	5,000
Estimated Future Payment After 1 year	$ 20,000
8% automobile loan payable [Member]
Debt Instrument [Line Items]
Maturity Date	October 2,021
Stated Interest Rate	8.00%
Carrying Value	$ 16,000
Estimated Future Payment Within 1 Year	3,000
Estimated Future Payment After 1 year	$ 13,000

STOCKHOLDERS' EQUITY (Details T

STOCKHOLDERS' EQUITY (Details Textual) - USD ($)	1 Months Ended	9 Months Ended
	Dec. 21, 2016	Jan. 31, 2017	Apr. 30, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Preferred Stock, Par or Stated Value Per Share		$ 0.0001	$ 0.0001
Series H Convertible Preferred Stock [Member] | Common Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Issued During Period, Shares, Conversion of Units		263,000
Series H Convertible Preferred Stock [Member] | Preferred Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Issued During Period, Shares, Conversion of Units		2,630
Series H-1 Preferred Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividends		$ 378,000
Series H-1 Preferred Stock [Member] | Common Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Issued During Period, Shares, Conversion of Units		383,000
Series H-1 Preferred Stock [Member] | Preferred Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Issued During Period, Shares, Conversion of Units		(3,830)
Series H-2 Convertible Preferred Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair Value Of Warrants		$ 462,000
Fair Value Of Convertible Preferred Stock		$ 231,000
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term		5 years
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate		238.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate		2.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate		0.00%
Proceeds from Issuance of Warrants	$ 462,000
Series H-2 Convertible Preferred Stock [Member] | Securities Purchase Agreement [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Preferred Stock, Par or Stated Value Per Share	$ 0.0001
Number Shares To Be Issued	3,305
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	495,750
Series H-2 Convertible Preferred Stock [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	1.21
Series H-2 Preferred Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Debt Instrument, Convertible, Conversion Price		$ 0.60
Debt Instrument, Convertible, Beneficial Conversion Feature		$ 183,000

INCOME FROM ARBITRATION SETTL38

INCOME FROM ARBITRATION SETTLEMENT (Details Textual) - USD ($)	1 Months Ended	3 Months Ended		9 Months Ended
	Jun. 16, 2016	Jan. 31, 2017	Jan. 31, 2016	Jan. 31, 2017	Jan. 31, 2016
Proceeds from Legal Settlements		$ 0	$ 0	$ 0	$ 400,000
Cooper Medical School [Member]
Proceeds from Legal Settlements	$ 1,150,000